vs
Side-by-side financial comparison of Broadstone Net Lease, Inc. (BNL) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Broadstone Net Lease, Inc. is the larger business by last-quarter revenue ($118.3M vs $62.1M, roughly 1.9× Cytek Biosciences, Inc.). Broadstone Net Lease, Inc. runs the higher net margin — 28.0% vs -70.9%, a 98.9% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 5.5%). Broadstone Net Lease, Inc. produced more free cash flow last quarter ($269.8M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.0%).
Broadstone Net Lease, Inc. is a real estate investment trust (REIT) that acquires, owns, and manages a diversified portfolio of single-tenant commercial real estate assets across the United States. Its portfolio covers key segments including industrial facilities, healthcare properties, retail locations, and office spaces, all leased to tenants under long-term net lease agreements.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
BNL vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $118.3M | $62.1M |
| Net Profit | $33.1M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | — | -9.0% |
| Net Margin | 28.0% | -70.9% |
| Revenue YoY | 5.5% | 8.1% |
| Net Profit YoY | 25.5% | -557.1% |
| EPS (diluted) | $0.17 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $118.3M | $62.1M | ||
| Q3 25 | $114.2M | $52.3M | ||
| Q2 25 | $113.0M | $45.6M | ||
| Q1 25 | $108.7M | $41.5M | ||
| Q4 24 | $112.1M | $57.5M | ||
| Q3 24 | $108.4M | $51.5M | ||
| Q2 24 | $105.9M | $46.6M | ||
| Q1 24 | $105.4M | $44.9M |
| Q4 25 | $33.1M | $-44.1M | ||
| Q3 25 | $26.5M | $-5.5M | ||
| Q2 25 | $20.2M | $-5.6M | ||
| Q1 25 | $16.7M | $-11.4M | ||
| Q4 24 | $26.4M | $9.6M | ||
| Q3 24 | $35.6M | $941.0K | ||
| Q2 24 | $35.3M | $-10.4M | ||
| Q1 24 | $65.1M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | — | -9.0% | ||
| Q3 25 | — | -17.6% | ||
| Q2 25 | — | -23.3% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | -8.2% | ||
| Q2 24 | — | -18.3% | ||
| Q1 24 | — | -23.9% |
| Q4 25 | 28.0% | -70.9% | ||
| Q3 25 | 23.2% | -10.5% | ||
| Q2 25 | 17.8% | -12.2% | ||
| Q1 25 | 15.4% | -27.5% | ||
| Q4 24 | 23.5% | 16.8% | ||
| Q3 24 | 32.8% | 1.8% | ||
| Q2 24 | 33.4% | -22.4% | ||
| Q1 24 | 61.8% | -13.8% |
| Q4 25 | $0.17 | — | ||
| Q3 25 | $0.14 | — | ||
| Q2 25 | $0.10 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.13 | — | ||
| Q3 24 | $0.19 | — | ||
| Q2 24 | $0.19 | — | ||
| Q1 24 | $0.35 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.5M | $90.9M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.9B | $341.7M |
| Total Assets | $5.7B | $461.5M |
| Debt / EquityLower = less leverage | 0.87× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.5M | $90.9M | ||
| Q3 25 | $82.0M | $93.3M | ||
| Q2 25 | $20.8M | $75.5M | ||
| Q1 25 | $9.6M | $95.3M | ||
| Q4 24 | $14.8M | $98.7M | ||
| Q3 24 | $9.0M | $162.3M | ||
| Q2 24 | $18.3M | $177.9M | ||
| Q1 24 | $221.7M | $168.8M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $2.9B | $341.7M | ||
| Q3 25 | $2.9B | $378.6M | ||
| Q2 25 | $2.9B | $377.6M | ||
| Q1 25 | $2.9B | $379.6M | ||
| Q4 24 | $3.0B | $395.7M | ||
| Q3 24 | $3.0B | $385.5M | ||
| Q2 24 | $3.1B | $389.1M | ||
| Q1 24 | $3.1B | $392.6M |
| Q4 25 | $5.7B | $461.5M | ||
| Q3 25 | $5.5B | $494.9M | ||
| Q2 25 | $5.3B | $493.3M | ||
| Q1 25 | $5.2B | $482.6M | ||
| Q4 24 | $5.2B | $499.5M | ||
| Q3 24 | $5.3B | $491.2M | ||
| Q2 24 | $5.3B | $483.7M | ||
| Q1 24 | $5.3B | $492.1M |
| Q4 25 | 0.87× | — | ||
| Q3 25 | 0.82× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.68× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.65× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $299.5M | $-771.0K |
| Free Cash FlowOCF − Capex | $269.8M | $-1.8M |
| FCF MarginFCF / Revenue | 228.1% | -2.9% |
| Capex IntensityCapex / Revenue | 25.1% | 1.6% |
| Cash ConversionOCF / Net Profit | 9.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | $461.6M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $299.5M | $-771.0K | ||
| Q3 25 | $64.2M | $-3.9M | ||
| Q2 25 | $79.3M | $108.0K | ||
| Q1 25 | $71.5M | $-125.0K | ||
| Q4 24 | $276.3M | $2.0M | ||
| Q3 24 | $67.3M | $13.2M | ||
| Q2 24 | $74.2M | $6.2M | ||
| Q1 24 | $70.9M | $4.0M |
| Q4 25 | $269.8M | $-1.8M | ||
| Q3 25 | $58.0M | $-4.6M | ||
| Q2 25 | $76.7M | $-1.5M | ||
| Q1 25 | $57.1M | $-974.0K | ||
| Q4 24 | $259.5M | $1.1M | ||
| Q3 24 | $60.3M | $12.2M | ||
| Q2 24 | $74.0M | $5.2M | ||
| Q1 24 | $67.7M | $3.4M |
| Q4 25 | 228.1% | -2.9% | ||
| Q3 25 | 50.8% | -8.7% | ||
| Q2 25 | 67.9% | -3.2% | ||
| Q1 25 | 52.5% | -2.3% | ||
| Q4 24 | 231.4% | 1.9% | ||
| Q3 24 | 55.6% | 23.7% | ||
| Q2 24 | 69.9% | 11.0% | ||
| Q1 24 | 64.3% | 7.6% |
| Q4 25 | 25.1% | 1.6% | ||
| Q3 25 | 5.4% | 1.3% | ||
| Q2 25 | 2.3% | 3.5% | ||
| Q1 25 | 13.2% | 2.0% | ||
| Q4 24 | 15.0% | 1.6% | ||
| Q3 24 | 6.5% | 2.0% | ||
| Q2 24 | 0.2% | 2.3% | ||
| Q1 24 | 3.0% | 1.3% |
| Q4 25 | 9.04× | — | ||
| Q3 25 | 2.43× | — | ||
| Q2 25 | 3.93× | — | ||
| Q1 25 | 4.27× | — | ||
| Q4 24 | 10.47× | 0.21× | ||
| Q3 24 | 1.89× | 14.05× | ||
| Q2 24 | 2.10× | — | ||
| Q1 24 | 1.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNL
| Other | $66.9M | 57% |
| Two Thousand Twenty Four Atm Program | $51.4M | 43% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
